Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Gemini Stock Down 80% From IPO Peak; $753M Valuation Revives Takeover Speculation as Regulatory Licenses Become Acquisition Target

by Team Lumida
September 21, 2026
in Equities
Reading Time: 5 mins read
A A
0
Gemini Stock Down 80% From IPO Peak; $753M Valuation Revives Takeover Speculation as Regulatory Licenses Become Acquisition Target
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • Gemini Space Station (GEMI), the crypto platform founded by billionaire Winklevoss twins, has seen its stock plunge roughly 80% since IPO, reviving takeover speculation. Market value collapsed from ~$4 billion at peak to $753 million currently. Q2 2025 exchange revenue fell 38% year-on-year to $12.5 million; spot trading volume dropped 66% to $3.8 billion; platform assets declined to $8.4 billion from $18.2 billion. ARK Invest’s Lorenzo Valente proposed on X that Hyperliquid (offshore perpetual-trading platform) should acquire Gemini to establish regulated U.S. gateway for perpetual futures and prediction markets, with Winklevoss twins’ voting control potentially simplifying deal execution.
  • Gemini’s core value to potential acquirer lies not in spot-exchange business (shrinking and offering limited differentiation) but in regulatory infrastructure: licenses, custody approvals, and market access would be costly/time-consuming for competitors to replicate organically. Venture capital investors told CoinDesk buyers weight acquisition cost vs. legal fees and timeline for organic license acquisition. Pattern in crypto M&A: buyers increasingly pay for regulatory infrastructure and distribution rather than trading volume. Examples: Keyrock acquired BlockFills’ assets for regulatory licenses/institutional clients; Ondo exploring $500M+ tokenization deal; LMAX and B2C2 pursuing strategic transactions. CoinDesk reported April 2025 that prospective buyers considered Gemini’s shuttered European/UK operations primarily for regulatory licenses; deal stalled amid valuation disagreements.
  • Winklevoss twins hold 94.5% voting control of Gemini, meaning any deal negotiations run through two people, simplifying process but also enabling them to block hostile takeover or shareholder-driven transaction. Low valuation ($753M) offers potential acquirer inexpensive route to Gemini’s regulatory licenses, customer base, and custody infrastructure. However, question remains: would Winklevoss brothers agree to sell? Their voting control effectively makes them gatekeepers for any transaction, removing shareholder pressure to accept offers.
  • Gemini’s regulatory licenses and U.S. infrastructure are valuable to offshore competitor like Hyperliquid seeking regulated pathway into U.S. derivatives market. If Hyperliquid acquires Gemini, it would gain immediate U.S. regulatory standing, customer relationships, and custody infrastructure—enabling rapid launch of U.S.-compliant perpetual futures and prediction markets. This would create direct competition to CME and ICE in crypto derivatives and threaten Coinbase’s spot exchange market share. For Winklevoss twins, decision to sell at $753M valuation vs. turnaround effort depends on belief in Gemini’s recovery trajectory and opportunity cost of capital deployed elsewhere.

What Happened?

Gemini (GEMI) stock down 80% from IPO peak, with market cap falling from ~$4 billion to $753 million. Q2 exchange revenue fell 38% YoY to $12.5M; spot trading volume down 66% to $3.8B; platform assets declined to $8.4B from $18.2B. Takeover speculation revived with ARK Invest’s Lorenzo Valente proposing Hyperliquid (offshore perpetual platform) acquire Gemini for regulated U.S. regulatory gateway. Potential buyers value Gemini’s regulatory licenses, custody infrastructure, and market access more than shrinking spot exchange business. Winklevoss twins hold 94.5% voting control, simplifying deal negotiations but enabling them to block any transaction. CoinDesk reported April that prospective buyers considered Gemini’s European/UK operations for regulatory licenses only; deal stalled on valuation. Pattern in crypto M&A shows buyers increasingly purchasing for regulatory infrastructure vs. trading volume.

Why It Matters?

For Gemini shareholders, low valuation ($753M) creates takeover opportunity but only if Winklevoss twins decide to sell. If no acquisition materializes, shareholders face continued decline as trading volumes shrink and losses mount. For Hyperliquid, Gemini acquisition would provide regulated U.S. gateway enabling perpetual futures/prediction market launch—transforming offshore platform into U.S. competitor. For Coinbase (COIN), Gemini acquisition by rival could consolidate market share and reduce competition but also signal M&A risk for COIN itself. For CME and ICE, Hyperliquid-Gemini combination would create direct crypto derivatives competition threatening their Bitcoin/Ethereum futures business. For cryptocurrency market structure, Gemini acquisition would validate that regulatory licenses are highest-value crypto assets—more valuable than trading volumes or product differentiation.

What’s Next?

Monitor Gemini’s trading volume and revenue metrics; if Q3 continues Q2’s decline trajectory, it could increase acquisition pressure. Watch for Hyperliquid strategic announcements; if Hyperliquid confirms interest in U.S. regulatory expansion, Gemini becomes likely target. Track Winklevoss twins’ public commentary; if they signal openness to acquisition or partnerships, deal could accelerate. Monitor regulatory developments; if CFTC approves new rules enabling offshore platforms to acquire regulated U.S. exchanges, it could facilitate Hyperliquid-Gemini deal. Watch CME and ICE earnings guidance on crypto derivatives; if they warn of potential competitive pressure from new U.S.-regulated perpetual platforms, it would validate deal risk. Track cryptocurrency funding activity; if Gemini raises capital, it would signal Winklevoss confidence in turnaround vs. sale. Also monitor Coinbase’s strategic positioning; if COIN pursues acquisitions or announces defensive moves, it could indicate concern about Gemini becoming acquired competitor.

Affected Tickers & Coins: GEMI, COIN, ICE, CME

Source: CoinDesk

Previous Post

Kalshi Faces Fake Volume Allegations on Crypto Perpetuals; $539M 24-Hour ETH Volume vs $3.1M Open Interest Triggers Wash Trading Questions

Next Post

Bitcoin Above $81K After SEC Tokenized Stock Approval; NEAR Jumps 23% as NEAR Intents Zcash Swap Volume Surges 6x in One Week

Recommended For You

AbbVie Beats by 9 Cents as Immunology Sales Jump 16% to $9.17 Billion, Lifting Its Profit Outlook and Raising Its Dividend 5.2% to $1.82

by Team Lumida
1 day ago

AbbVie’s Q3 revenue rose 10% to $17.4 billion on Skyrizi and Rinvoq, and it raised full-year guidance above Wall Street’s forecast.

Read more

BofA Downgrades Intel as Five Firms Cut Price Targets After Its Guidance Miss, While Jefferies Upgrades Rivian and Morgan Stanley Keeps Amazon as a Top Pick

by Team Lumida
1 day ago

BofA cut Intel to neutral as four other firms slashed targets, while Jefferies upgraded Rivian and HSBC lifted GE Vernova to buy on Friday.

Read more

Exxon’s Profit Doubles to $15.4 Billion and Chevron’s Jumps Nearly 200% as a Global Diesel Crunch Turns Refining Into Their Biggest Earner

by Team Lumida
1 day ago

Exxon earned $15.4 billion and Chevron $9.9 billion in Q3 as US Gulf Coast refineries ran flat out to fill a global diesel shortage.

Read more

Reddit Sinks 18% After Hours on Soft Guidance as Google’s AI Search Cuts Referral Traffic, Pushing It to Test Mandatory Logins

by Team Lumida
2 days ago

Reddit beat Q3 estimates, but its Q4 sales guide missed, US daily users fell 2%, and it will test requiring users to log in.

Read more

Intel Plunges About 21% After Hours as Weak Fourth-Quarter Guidance and a PC Slowdown Overshadow 78% Data Center Growth

by Team Lumida
2 days ago
Intel Surges 5%, SK Hynix Up 3% on Reports of U.S. Memory Chip Manufacturing Deal to Serve Nvidia and AI Demand

Intel guided Q4 revenue to $15 billion to $16 billion versus $17.1 billion expected and warned the PC slowdown will last into 2027.

Read more

Amazon Slides More Than 6% as $77.3 Billion of Quarterly Capex Pushes Free Cash Flow to Negative $42.4 Billion, Even as AWS Posts Its Fastest Growth Since 2021

by Team Lumida
2 days ago
Amazon’s $100 Billion Bet: AI Over Retail

Amazon missed on EPS and revenue and burned cash on AI spending, but AWS grew 39% and Andy Jassy sees growth above 40% in 2027 and 2028.

Read more

D.R. Horton Misses by 35 Cents and Forecasts About 5,000 Fewer Home Closings Next Year, Saying Expecting Rate Cuts Would Be ‘Imprudent’

by Team Lumida
2 days ago

D.R. Horton earned $2.67 a share vs. $3.02 expected and sees as few as 79,000 closings in fiscal 2027, down from about 84,000, with incentives staying high.

Read more

Mastercard Beats by 14 Cents as Revenue Jumps 14% to $9.81 Billion and Its Fraud and Data Services Arm Grows 19%

by Team Lumida
2 days ago
person holding debit card

Mastercard earned an adjusted $5.31 a share vs. $5.17 expected on 14% revenue growth to $9.81 billion, lifted by payments volume and services.

Read more

Josh Kushner’s Thrive Holdings Will Buy ADT for $7.6 Billion in Cash at a 35% Premium, Betting AI Can Remake the Home-Security Giant

by Team Lumida
2 days ago

Thrive Holdings will pay $10 a share in cash for ADT, a 35% premium, in a deal valued at $15.3 billion including debt and backed by Apollo financing.

Read more

Merck Beats by 41 Cents and Raises Its Profit Outlook as Keytruda’s New Shot Hits a Record $830 Million Ahead of the 2028 Patent Cliff

by Team Lumida
2 days ago

Merck topped Q3 estimates with $2.49 adjusted EPS and $18.09 billion in revenue, raised its profit outlook and saw Keytruda Qlex sales beat by $181 million.

Read more
Next Post
Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Bitcoin Above $81K After SEC Tokenized Stock Approval; NEAR Jumps 23% as NEAR Intents Zcash Swap Volume Surges 6x in One Week

Chinese Biopharma Stocks Surge on U.S. Regulatory Openness; Innovent +6-7%, Akeso +8%, CSPC +6% as Treasury Drafts Pharma Licensing Rules

Chinese Biopharma Stocks Surge on U.S. Regulatory Openness; Innovent +6-7%, Akeso +8%, CSPC +6% as Treasury Drafts Pharma Licensing Rules

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Fed Official Warns of Inflation Risks Under Trump Presidency

Junk Bond Market Rushes to Beat Trump’s Tariff Timeline

January 17, 2025
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

China’s Central Bank Focuses on Enhancing Domestic Consumption

August 3, 2024
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Trump Tariffs Drive China’s Trade Pivot to Global South, Creating New Commerce Order

August 19, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018